Dec 31 - A major new study of people at risk for stroke showed that two medical procedures designed to prevent future strokes are safe and effective overall. Physicians will now have more options in tailoring treatments for their patients at risk for strok... Read more »
Mar 1 - On Feb. 8 the U.S. Food and Drug Administration approved the cholesterol-lowering medication Crestor (rosuvastatin) for some patients who are at increased risk of heart disease but have not been diagnosed with it. The new indication is for reduci... Read more »
Feb 9 - A nurse-led behavioral intervention can reduce the incidence of depression in stroke survivors, according to the results of a study published in the recent issue of the journal Stroke. The intervention, called Living Well with Stroke (LWWS), provi... Read more »
Aug 11 - Scientists have devised a new computational model that can be used to reveal genetic regulatory elements responsible for development of the human heart and maintenance of its function. Although the teams focused on the heart, the computational me... Read more »
Feb 22 - In recognition of American Heart Month, the National Heart, Lung, and Blood Institute (NHLBI) and its heart disease awareness campaign - The Heart Truth - is reminding all American women that heart disease prevention remains critically important, ... Read more »
Feb 8 - The U.S. Food and Drug Administration today approved the HeartMate II, a continuous-flow, left ventricular assist system as a support for severe heart failure patients who are not acceptable candidates for heart transplantation. Read more »
Jan 20 - Patients should avoid using the stomach acid reducer Prilosec/Prilosec OTC (omeprazole) with the anti-clotting drug Plavix (clopidogrel), the U.S. Food and Drug Administration warned on Nov. 17. New data suggest that when patients take both Prilo... Read more »